Icon is one of a handful of global contract research organizations with the infrastructure to carry out large, late-stage clinical trials. While Icon operates on a significant global scale with extensive regulatory knowledge, we no longer view its advantages as durable enough to maintain adjusted returns on invested capital exceeding its cost of capital over the next decade.
If biotech funding recovers and clinical trial starts increase, this could improve bookings growth, lower cancellations, and return to mid‑single‑digit revenue growth.
Drawbacks to biotech funding or declines in outsourcing penetration rates could have a material impact on Icon's growth.
|
Metric
|
ICLR
|
IQV
|
FTRE
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.61 | 20.91 | 145.12 |
Price/Book Value | 1.33 | 6.95 | 3.52 |
Price/Sales | 1.51 | 2.61 | 0.67 |
Price/Cash Flow | 13.08 | 16.94 | 34.53 |
|
Metric
|
ICLR
|
IQV
|
FTRE
|
|---|---|---|---|
Quick Ratio | 0.92 | 0.62 | 0.85 |
Current Ratio | 0.95 | 0.71 | 0.96 |
Interest Coverage | 1.53 | 2.99 | 0.08 |
|
Metric
|
ICLR
|
IQV
|
FTRE
|
|---|---|---|---|
Return on Assets (Normalized) | 3.91% | 7.22% | 2.15% |
Return on Equity (Normalized) | 6.87% | 34.41% | 10.56% |
Return on Invested Capital (Normalized) | 6.21% | 12.37% | 7.32% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#$Y&xFsF | LOCK|&> | $241B | |||
| Danaher Corp
DHR
| LOCK|WKK?!&y^ | LOCK|<^ | $149B | |||
| Agilent Technologies Inc
A
| LOCK|^GKBF@& | LOCK|ZwN | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|&Vy?%K@ | LOCK|Nn<j! | $43B | |||
| Waters Corp
WAT
| LOCK|!p@!g# | LOCK|vv | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|db<!NBf | LOCK|QZ | $41B | |||
| Illumina Inc
ILMN
| LOCK|%Z!$rr% | LOCK|jXCn | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|MlK^!#gf | LOCK|%HGvx | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|g>TTc@V | LOCK|@@@! | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|VK?s?f? | LOCK|S!#MJ | $25B |
United States